| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 06/02/2004 | EP1423367A1 Solvates of lercanidipine hydrochloride and new crystalline forms of lercanidipine hydrochloride |
| 06/02/2004 | EP1423366A1 Cyclopenta b ! indole derivatives as spla2 inhibitors |
| 06/02/2004 | EP1423364A1 Crystalline forms of 'r-(r*,r*)!-2-(4-fluorophenyl)-beta, delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-'phenylamino)carbonyl!-1h-pyrrole-1-heptanoic acid calcium salt (2:1) (atorvastatin) |
| 06/02/2004 | EP1423363A1 Oral antidiabetic agents |
| 06/02/2004 | EP1423359A1 C2-disubstituted indane-1-ones and their derivatives, method for their production and their use as medicaments |
| 06/02/2004 | EP1423358A1 Polysubstituted indan-1-ol systems, method for the production and use thereof as drugs |
| 06/02/2004 | EP1423176A2 Method and apparatus for removal of insulin binding proteins (ibp) from biological fluids |
| 06/02/2004 | EP1423139A2 New use of artemin, a member of the gdnf ligand family |
| 06/02/2004 | EP1423132A2 Complex mixtures exhibiting selective inhibition of cyclooxygenase-2 |
| 06/02/2004 | EP1423123A1 Tetracyclic indole derivatives as 5-ht receptor ligands |
| 06/02/2004 | EP1423109A2 Compositions comprising pectin and ascorbic acid |
| 06/02/2004 | EP1423107A2 Fatty alcohol drug conjugates |
| 06/02/2004 | EP1423106A1 Arylsulfonyl derivatives with 5-ht 6 receptor affinity |
| 06/02/2004 | EP1423002A1 Use of cross-linked, covalently bound urokinase plasminogen activator (scupa)-urokinase plasminogen activator receptor (supar) complex as a fibrinolytic agent |
| 06/02/2004 | EP1326613B1 Use of substituted imidazo 1,2-a]pyridine-, imidazo [1,2-a]pyrimidine and imidazo [1,2-a]pyrazine-3-yl-amine derivatives for producing nos-inhibiting medicaments |
| 06/02/2004 | EP1227824B1 Transplant/implant device and method for its production |
| 06/02/2004 | EP1171113B1 Compounds useful as phosphotyrosine mimics |
| 06/02/2004 | EP1164865B1 Method for selectively altering body fat level, feed efficiency, or weight gain |
| 06/02/2004 | EP1156795B1 Use of succinic acid or salts thereof and method of treating insulin resistance |
| 06/02/2004 | EP1123097B1 Pharmaceutical composition containing decursin |
| 06/02/2004 | EP1114032B1 4-amino substituted-2-substituted-1,2,3,4-tetrahydroquinolines as cetp inhibitors |
| 06/02/2004 | EP1039900B1 Pharmaceutical composition containing sibutramine and orlistat |
| 06/02/2004 | CN1501941A Chemical compounds |
| 06/02/2004 | CN1501938A Dicarba-closo-dodecaborane derivatives |
| 06/02/2004 | CN1501937A Spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors |
| 06/02/2004 | CN1501930A Novel pyridine- and cyclohexenyl-comprising pyrrolobenzodiazepi ne-carboxamides and derivatives thereof; tocolytic oxytocin receptor antagonists |
| 06/02/2004 | CN1501915A Bipiperidinyl-derivatives and their use as chemokine receptor inhibitors |
| 06/02/2004 | CN1501909A Novel succinate salt of o-desmethyl-venlafaxine |
| 06/02/2004 | CN1501903A Stable solution of reduced coenzyme q |
| 06/02/2004 | CN1501827A Ligands of the alpha-v-beta 6 integrin |
| 06/02/2004 | CN1501809A Chronic treatment regimen using glucagon-like insulinotropic peptides |
| 06/02/2004 | CN1501796A Treatment of type 2 diabetes mellitus using inhibitors of dipeptidyl peptidase IV |
| 06/02/2004 | CN1500781A Inhibitors of interleukin-1 beta converting enzyme |
| 06/02/2004 | CN1500532A Product capable of emitting far infrared and method of using far infrared |
| 06/02/2004 | CN1500523A Protein preparation for enhancing sclerotin and its preparation method |
| 06/02/2004 | CN1500482A Drug for diminishing inflammation and antibiosis |
| 06/02/2004 | CN1500408A Edible oil palm fibre powder ,food containing the same and production method |
| 06/02/2004 | CN1152049C Treatment of insulin resistance with growth hormone secretagogues |
| 06/02/2004 | CN1152042C Partial or full A agonists-N heterocyclic 5' thio substituted adenosine devivatives |
| 06/02/2004 | CN1152039C Benzo (b) thiepine-1, 1-dioxide derivatives, producing method thereof, combination containing the same and uses thereof |
| 06/02/2004 | CN1152030C Novel heterocyclic compounds |
| 06/02/2004 | CN1152027C Polycyclic thiazole-2-subunit amines, producing process and uses in preparing medicament thereof |
| 06/02/2004 | CN1152026C Polycyclic 2-amino thiazoline systems, producing process and uses as medicament thereof |
| 06/02/2004 | CN1152025C Substituted benzylthiazolidine-2,4-dione derivatives |
| 06/02/2004 | CN1152024C Substituted 3-phenyl-5-alkoxl-1,3,4-oxidazol-2-ones and use as lipase inhibitors thereof |
| 06/02/2004 | CN1152021C Intermediate for preparing corticotropin release factors antagonistic agent and preparing method thereof |
| 06/02/2004 | CN1151838C Use of proteins as agents against autoimmune diseases |
| 06/02/2004 | CN1151833C Capsule for reducing blood-lipid and preventing thrombosis |
| 06/02/2004 | CN1151825C Health tonic for delaying senility and regualting blood lipid |
| 06/02/2004 | CN1151821C Grape seed oil preparation and its extracting process |
| 06/02/2004 | CN1151818C Diabetes treating traditional Chinese medicine |
| 06/02/2004 | CN1151800C Medicine for curing diabetic peripheral nervous lesion |
| 06/02/2004 | CN1151785C Pharmaceutical composition comprising combination of metformin and fibrate, and its use in preparation of medicine for hyperglycemia |
| 06/02/2004 | CN1151783C Delayed-release dosage forms of sertraline |
| 06/02/2004 | CN1151776C Clear hydroalcoholic multivitamin solution containing physiologically effective amounts of beta-carotene |
| 06/01/2004 | USRE38524 Dipeptide derivatives as growth hormone secretagogues |
| 06/01/2004 | US6743900 Viral protein antigen (especially influenza virus hemagglutinin), proteosome preparation and detergent; removing detergent by diafiltration or ultrafiltration |
| 06/01/2004 | US6743791 Heterocyclic inhibitors of ERK2 and uses thereof |
| 06/01/2004 | US6743788 Carbamate and oxamide compounds |
| 06/01/2004 | US6743787 For therapy of metabolic disorders mediated by insulin resistance or hyperglycemia in a mammal |
| 06/01/2004 | US6743778 Apo-AI/AII peptide derivatives |
| 06/01/2004 | US6743775 Slow release formulations comprising anionic polysaccharide |
| 06/01/2004 | US6743414 Bone disorders; osteoporosis |
| 06/01/2004 | CA2293336C Methods of using isomer enriched conjugated linoleic acid compositions |
| 05/27/2004 | WO2004044199A1 Screening method |
| 05/27/2004 | WO2004043968A1 N-sulfonylaminothiazole |
| 05/27/2004 | WO2004043958A1 Fused heterocyclic compounds |
| 05/27/2004 | WO2004043957A1 Imidazopyridine derivatives, preparation method and pharmaceutical compositions containing same |
| 05/27/2004 | WO2004043956A1 Pyridopyrimidinone compounds, method for production thereof and medicaments comprising the same |
| 05/27/2004 | WO2004043951A1 Pyrazole derivatives as modulators of peroxisome proliferator activated receptors |
| 05/27/2004 | WO2004043947A1 Novel pyridine derivatives, preparation method and pharmaceutical compositions containing same |
| 05/27/2004 | WO2004043940A1 Phenylalanine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 05/27/2004 | WO2004043918A2 Novel crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms |
| 05/27/2004 | WO2004043907A1 Novel phenylnaphthalene derivatives, method for production thereof and pharmaceutical compositions comprising the same |
| 05/27/2004 | WO2004043468A1 Screening method |
| 05/27/2004 | WO2004043458A1 Bicyclic-substituted amines as histamine-3 receptor ligands |
| 05/27/2004 | WO2004031160A3 2-thiohydantoine derivative compounds and use thereof for the treatment of diabetes |
| 05/27/2004 | WO2004026816A8 Aromatic liver x-receptor modulators |
| 05/27/2004 | WO2004009597A3 Pyrazolopyrimidines as protein kinase inhibitors |
| 05/27/2004 | WO2003088908A3 Heterocyclo inhibitors of potassium channel function |
| 05/27/2004 | WO2003073986A3 Aminoalkylphosphonates and related compounds as edg receptor agonists |
| 05/27/2004 | WO2003033685A3 Method of producing human beta cell lines |
| 05/27/2004 | WO2003016276A3 3-substituted oxindole beta-3 agonists |
| 05/27/2004 | WO2003011262A3 Use of 2-alkoxyphenyl-substituted imidazotriazinones for the treatment of diseases associated with cgmp regulated processes |
| 05/27/2004 | WO2003006002A8 Compositions and methods of administering tubulin binding agents for the treatment of ocular diseases |
| 05/27/2004 | WO2003000295A3 Self-emulsifying formulations of cholesteryl ester transfer protein inhibitors |
| 05/27/2004 | WO2002097037A8 Melanin-concentrating hormone analogs |
| 05/27/2004 | WO2002090375A8 Liver x receptor agonists |
| 05/27/2004 | WO2002060480A9 Methods for treating or preventing skin disorders using cd2-binding agents |
| 05/27/2004 | US20040102634 For therapy and prophylaxis of hyperglycemia, hyperlipemia and inflammatory disease |
| 05/27/2004 | US20040102626 Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines with adenosine receptor-binding activity and their use cardiovascular preparations |
| 05/27/2004 | US20040102527 Use of cyclohexenone derivatives in the manufacture of a medicament for treating diabetic complications |
| 05/27/2004 | US20040102512 Statins reduce or repress T-lymphocyte activation mediated by MHC class II or CD40; new target is alternative to cytokine inhibitors |
| 05/27/2004 | US20040102510 Cancer; the compounds interact with the amino acids in the catalytic region of PKs and bind in the general space normally occupied by the adenine ring of ATP |
| 05/27/2004 | US20040102508 Naphathalene derivatives which bind to the ep4 receptor |
| 05/27/2004 | US20040102506 Pyrazole compositions useful as inhibitors of ERK |
| 05/27/2004 | US20040102500 Peroxisome proliferator activated receptor alpha agonists |
| 05/27/2004 | US20040102496 Non-peptidyl inhibitors of VLA-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases |
| 05/27/2004 | US20040102493 Compound of formula (I) for the manufacture of a medicament for the prevention or treatment of a hPPAR mediated disease or hypercholesteremia, cardiovascular disease, type II diabetes obesity, anorexia bulimia, inflammation and anorexia |
| 05/27/2004 | US20040102490 Antilipemic agents, antidiabetic agents and treatment of obesity |